BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 12, 2024
See today's BioWorld Asia
Home
» Sirnaomics files first China IND for siRNA trial; U.S. filing next
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Sirnaomics files first China IND for siRNA trial; U.S. filing next
Jan. 14, 2015
By
Shannon Ellis
No Comments
SHANGHAI – Sirnaomics Inc. is a biopharma straddling the pacific. While one half is in China, with facilities in Suzhou and Guangzhou, it calls Gaithersburg, Md., its headquarters, where the company first got its start seven years ago.
BioWorld Asia